Prasugrel
CAS 150322-43-3 10 FDA-DMF suppliersSmall Molecule
Overview
Prasugrel is an oral antiplatelet medication that is used to reduce the risk of thrombotic cardiovascular events in patients with acute coronary syndrome. It works by inhibiting platelet aggregation through the irreversible antagonism of the P2Y12 platelet ADP-receptor.
API suppliers (4)
Suppliers of Prasugrel backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- RUYUAN HEC PHARM CO LTD1 active DMF
- Dr. Reddy's Laboratories Ltd.India1 active DMF
- MATRIX PHARMACORP PRIVATE LTD1 active DMF
- Zakłady Farmaceutyczne Polpharma S.A.Poland
Therapeutic areas
CardiologyHematology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.